June 24-25, 2024 (8:30 a.m.-6 p.m.; 8:30 a.m.-3:30 p.m. ET)
Sponsors/Co-Sponsors
NICHD, NIH; National Institute of Allergy and Infectious Diseases, NIH
Location
Virtual/in-person hybrid; registration is free but required
5601 Fishers Lane, Great Hall (1D13), Rockville, MD 20852
Purpose
Multipurpose prevention technologies (MPTs) are designed to deliver combinations of HIV and other STI prevention and/or contraception. Research indicates that MPTs may significantly improve women's health globally by offering multiple safeguards in single products. Two dozen MPTs, using a range of delivery platforms such as intravaginal rings, films, gels, and implants, are currently in development. However, resource, regulatory, and other limitations can often slow research and clinical testing.
This summit, organized in partnership with the National Institute of Mental Health, NIH Office of AIDS Research, and the Initiative for MPTs, brings together stakeholders from the fields of HIV/STI prevention and contraception to explore what is needed to advance research and development and bring MPTs to market. Several NIH representatives are scheduled speak at the meeting.
Individuals who need reasonable accommodation to participate in this event should contact Leigh Allen at leigh.allen@nih.gov or 301-594-9151.
More Information
Contact
Leigh Allen, Contraception Research Branch, Division of Extramural Research, NICHD
Email: leigh.allen@nih.gov
Phone: 301-594-9151